Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 1 of 8 for:    DIPAK
Previous Study | Return to List | Next Study

Study of Lanreotide to Treat Polycystic Kidney Disease (DIPAK1)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Leiden University Medical Center
Erasmus Medical Center
Radboud University
Information provided by (Responsible Party):
dr. R.T. Gansevoort, University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT01616927
First received: June 6, 2012
Last updated: May 19, 2017
Last verified: May 2017